Gsa Capital Partners LLP Geo Vax Labs, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.75 $6,230 - $8,496	11,328 New	11,328 $6,000
Q4 2022 Feb 13, 2023	BUY	$0.55 - $17.1 $10,072 - $313,169	18,314 New	18,314 $12,000
Q1 2022 May 11, 2022	SELL	$17.25 - $58.95 $595,073 - $2.03 Million	-34,497 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$52.65 - $71.7 $349,806 - $476,374	-6,644 Reduced 16.15%	34,497 $125,000
Q3 2021 Nov 12, 2021	BUY	$56.4 - $91.35 $2.32 Million - $3.76 Million	41,141 New	41,141 $178,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $69.8M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.